Neurocrine Gains Clinical-Stage Schizophrenia Candidates Returned To Sosei By AbbVie

 
• By Jessica Merrill
hand shake
Neuocrine signed a licensing deal with Sosei Heptares • Source: Alamy

More from Deals

More from Business